Hancheng ZHANG

Person

Hangzhou, Zhejiang, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Heterocyclic comipound as CDK-HDAC dual pathway inhibitor
- Patent number 12,358,911
- Issue date Jul 15, 2025
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compound serving as FGFR4 inhibitor
- Patent number 11,352,353
- Issue date Jun 7, 2022
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual in...
- Patent number 11,266,640
- Issue date Mar 8, 2022
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocycles useful as anti-cancer agents
- Patent number 11,225,492
- Issue date Jan 18, 2022
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor
- Patent number 11,142,535
- Issue date Oct 12, 2021
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound containing tricyclic heteroaryl group
- Patent number 10,968,234
- Issue date Apr 6, 2021
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compound used as FGFR inhibitor
- Patent number 10,934,311
- Issue date Mar 2, 2021
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound containing tricyclic heteroaryl group
- Patent number 10,730,887
- Issue date Aug 4, 2020
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocycles useful as IDO and TDO inhibitors
- Patent number 10,358,451
- Issue date Jul 23, 2019
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUND AS KIF18A INHIBITOR
- Publication number 20250214965
- Publication date Jul 3, 2025
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND SERVING AS KAT6 INHIBITOR
- Publication number 20240400545
- Publication date Dec 5, 2024
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND SERVING AS NLRP3 INHIBITOR
- Publication number 20240336562
- Publication date Oct 10, 2024
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF A COMPOUND CONTAINING A TRICYCLIC HETEROARYL GROUP
- Publication number 20240165123
- Publication date May 23, 2024
- CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- Hanyu YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR
- Publication number 20230095043
- Publication date Mar 30, 2023
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONDENSED TRICYCLIC COMPOUND USED AS KINASE INHIBITOR
- Publication number 20220153766
- Publication date May 19, 2022
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic Compound as CDK-HDAC Double-Channel Inhibitor
- Publication number 20220041577
- Publication date Feb 10, 2022
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMIPOUND AS CDK-HDAC DUAL PATHWAY INHIBITOR
- Publication number 20220024916
- Publication date Jan 27, 2022
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUND AS SYK INHIBITOR AND/OR SYK-HDAC DUAL INHIBITOR
- Publication number 20220002318
- Publication date Jan 6, 2022
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND CONTAINING TRICYCLIC HETEROARYL GROUP
- Publication number 20200354376
- Publication date Nov 12, 2020
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYCYCLIC COMPOUND ACTING AS IDO INHIBITOR AND/OR IDO-HDAC DUAL IN...
- Publication number 20200276180
- Publication date Sep 3, 2020
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUND SERVING AS FGFR4 INHIBITOR
- Publication number 20200199120
- Publication date Jun 25, 2020
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUND AS SYK INHIBITOR AND/OR SYK-HDAC DUAL INHIBITOR
- Publication number 20200079795
- Publication date Mar 12, 2020
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND CONTAINING TRICYCLIC HETEROARYL GROUP
- Publication number 20190308993
- Publication date Oct 10, 2019
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUND USED AS FGFR INHIBITOR
- Publication number 20190100531
- Publication date Apr 4, 2019
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLES USEFUL AS ANTI-CANCER AGENTS
- Publication number 20180370991
- Publication date Dec 27, 2018
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLES USEFUL AS IDO AND TDO INHIBITORS
- Publication number 20180127418
- Publication date May 10, 2018
- Hangzhou Innogate Pharma Co., Ltd.
- Hancheng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Hancheng ZHANG

Person

Patents Grantslast 30 patents

Heterocyclic comipound as CDK-HDAC dual pathway inhibitor

Heterocyclic compound serving as FGFR4 inhibitor

Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual in...

Heterocycles useful as anti-cancer agents

Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor

Compound containing tricyclic heteroaryl group

Heterocyclic compound used as FGFR inhibitor

Compound containing tricyclic heteroaryl group

Heterocycles useful as IDO and TDO inhibitors

Patents Applicationslast 30 patents

COMPOUND AS KIF18A INHIBITOR

COMPOUND SERVING AS KAT6 INHIBITOR

COMPOUND SERVING AS NLRP3 INHIBITOR

USE OF A COMPOUND CONTAINING A TRICYCLIC HETEROARYL GROUP

POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR

CONDENSED TRICYCLIC COMPOUND USED AS KINASE INHIBITOR

Heterocyclic Compound as CDK-HDAC Double-Channel Inhibitor

HETEROCYCLIC COMIPOUND AS CDK-HDAC DUAL PATHWAY INHIBITOR

HETEROCYCLIC COMPOUND AS SYK INHIBITOR AND/OR SYK-HDAC DUAL INHIBITOR

COMPOUND CONTAINING TRICYCLIC HETEROARYL GROUP

POLYCYCLIC COMPOUND ACTING AS IDO INHIBITOR AND/OR IDO-HDAC DUAL IN...

HETEROCYCLIC COMPOUND SERVING AS FGFR4 INHIBITOR

HETEROCYCLIC COMPOUND AS SYK INHIBITOR AND/OR SYK-HDAC DUAL INHIBITOR

COMPOUND CONTAINING TRICYCLIC HETEROARYL GROUP

HETEROCYCLIC COMPOUND USED AS FGFR INHIBITOR

HETEROCYCLES USEFUL AS ANTI-CANCER AGENTS

HETEROCYCLES USEFUL AS IDO AND TDO INHIBITORS